About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
Patent applicants in Brazil experience some of the longest pendency times in the world. Brazil continues to experience significant patent examination delays, with average patent examinations for biopharmaceuticals taking longer than 9.5 years.
Significant Pharmaceutical Backlogs Remain in Brazil image
Fact Sheet
International
Significant Pharmaceutical Backlogs Remain in Brazil
Significant Pharmaceutical Backlogs Remain in Brazil image